๐งฌ Ozempic Shows First Clinical Evidence of Slowing Human Biological Aging
A randomized trial published in Nature Communications found that semaglutide โ the active ingredient in Ozempic and Wegovy โ slowed epigenetic aging markers by 9% in adults with HIV. The improvements appeared across markers for the brain, heart, liver, and kidneys, suggesting broad systemic effects. Scientists call it the first clinical evidence that a drug may influence human aging, though larger studies are still needed. Could GLP-1 drugs become the next frontier in anti-aging medicine?
โก 28 buzzing
249 views
๐ 0 subscribed